EUVIMEDTutustu EUVIMEDiin
Crossref

The Use of NMP22 and Urine Cytology for the Surveilance of Patients with Superficial Bladder Cancer

The Internet Journal of Urology · 2010

DOI: 10.5580/10fd ↗

At a glance

Journal article in The Internet Journal of Urology, 2010.

TiivistelmäBibliografiset tiedotCiteRelated studies

Abstract (original language)

Aim

To see if NMP22 combined with urine cytology can safely increase the interval between cystoscopies in the surveillance of superficial bladder cancers.

Methods

Thirty four patients with low grade superficial bladder transitional cell carcinomas were prospectively recruited and followed up with regular flexible cystoscopies over 2 years. Freshly voided urine was collected for urine cytology and NMP22 test prior to cystoscopy. Patients with suspicious cystoscopy findings or suspicious cytology underwent biopsies and/or resection of the suspicious lesions.

Results

172 urine samples were collected and analyzed. The NMP 22 results were compared with voided urine cytology, cystoscopy and histological findings. Using the 10U/ml cutoff for quantitative measurement, the sensitivity, specificity, positive and negative predictive values of urinary NMP22 were 50%, 90.7%, 21.0%, and 97.3% respectively. When combined with voided urine cytology, the sensitivity, specificity, positive and negative predictive values were 71.4%, 88.5%, 25.0%, and 98.3% respectively. In comparison, the sensitivity, specificity, positive and negative predictive value of cystoscopy were 85.7%, 97.6%, 66.7%, and 99.2% respectively. Analysis with a receiver operating characteristic(ROC) curve found the ideal threshold of determinance of NMP22 for the detection of recurrences is 8.5U/ml with 100% sensitivity and 73.9% specificity. In our center, replacing alternate cystoscopy examination at 3,9,18 and 30 months with NMP22, results in a cost saving USD$740 or 37% per patient over 5 years. In the event of false positives, the patient will revert to the current surveillance schedule, with no increased costs incurred.

Conclusion

We propose that the optimal cutoff value for NMP22 is 8.5U/ml. At this level. the combination of the NMP22 BladderChek test and voided urine cytology is a sensitive non-invasive alternative to cystoscopy in the surveillance of patients who have had superficial low grade bladder cancer.

Cite

APA

(2010). The Use of NMP22 and Urine Cytology for the Surveilance of Patients with Superficial Bladder Cancer. The Internet Journal of Urology. https://doi.org/10.5580/10fd

Vancouver

The Use of NMP22 and Urine Cytology for the Surveilance of Patients with Superficial Bladder Cancer. The Internet Journal of Urology. 2010. doi:10.5580/10fd

BibTeX
@article{euvimed2010,
  title = {The Use of NMP22 and Urine Cytology for the Surveilance of Patients with Superficial Bladder Cancer},
  journal = {The Internet Journal of Urology},
  year = {2010},
  doi = {10.5580/10fd}
}
Start for free →